Aridis Pharmaceuticals, Inc.
ARDS
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -98.14% | -99.70% | -89.42% | -73.06% | -89.65% |
| Total Receivables | 108.47% | -81.12% | -74.68% | 423.21% | -79.71% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -5.57% | 88.42% | 31.17% | 23.74% | 73.08% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -55.77% | -35.35% | 39.37% |
| Total Current Assets | -52.40% | -69.92% | -66.79% | -52.33% | -63.38% |
|
|
|||||
| Total Current Assets | -52.40% | -69.92% | -66.79% | -52.33% | -63.38% |
| Net Property, Plant & Equipment | -36.79% | -35.97% | -35.34% | 58.22% | 73.31% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -27.78% | -26.32% | -28.57% | -22.73% | -21.74% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -13.94% | -18.12% | -10.83% | -11.88% | -7.15% |
| Total Assets | -46.09% | -61.15% | -60.39% | -45.16% | -53.54% |
|
|
|||||
| Total Accounts Payable | 27.90% | 144.11% | 35.94% | -55.95% | 59.98% |
| Total Accrued Expenses | -9.45% | 12.41% | 47.44% | 47.96% | 29.48% |
| Short-term Debt | -- | -- | -- | -25.43% | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -52.10% | 929.77% | 311.76% | -- | -- |
| Total Finance Division Other Current Liabilities | -98.06% | -98.06% | -8.91% | -3.63% | 3.65% |
| Total Other Current Liabilities | -98.06% | -98.06% | -8.91% | -3.63% | 3.65% |
| Total Current Liabilities | -58.65% | -34.92% | 14.24% | 10.65% | 46.35% |
|
|
|||||
| Total Current Liabilities | -58.65% | -34.92% | 14.24% | 10.65% | 46.35% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -25.43% | -- |
| Capital Leases | -40.28% | -35.97% | -32.87% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -13.70% | -42.24% | -45.53% |
| Total Liabilities | -61.75% | -52.05% | -15.62% | -2.45% | 58.54% |
|
|
|||||
| Common Stock & APIC | 11.32% | 10.31% | 10.50% | 9.33% | 0.74% |
| Retained Earnings | -0.60% | -5.14% | -17.00% | -18.37% | -20.96% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 67.05% | 46.61% | -36.62% | -84.84% | -762.17% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 67.05% | 46.61% | -36.62% | -84.84% | -762.17% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 67.05% | 46.61% | -36.62% | -84.84% | -762.17% |
|
|
|||||